Kymera JPM Presentation_January 2025_R2.pdf

1、Nello Mainolfi,Ph.D.,Founder,President and CEOJ.P.Morgan Healthcare ConferenceJanuary 20252Forward Looking StatementsThis presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws.Thesestatements incl

2、ude,but are not limited to,implied and express statements about our strategy,business plans and objectives for our programs;plans and timelines for thepreclinical and clinical development of our product candidates,including the therapeutic potential,clinical benefits and safety profiles of such prod

3、uct candidates;expectationsregarding timing,success and data announcements of ongoing preclinical studies and clinical trials;our ability to initiate new clinical programs,including plans to submitinvestigational new drug(IND)applications;our ability to deliver additional investigational drugs into

4、the clinic by 2026;the initiation,timing,progress and results of ourcurrent and future preclinical studies and clinical trials of our current and prospective product candidates;our plans to develop and commercialize our current and any futureproduct candidates and the implementation of our business

5、model and strategic plans for our business,current;any future product candidates;and our financial condition andexpected cash runway into mid-2027.All statements other than statements of historical facts contained in this presentation,including express or implied statements regardingour strategy,fut

6、ure financial condition,future operations,projected costs,prospects,plans,objectives of management and expected market growth,are forward-lookingstatements.In some cases,you can identify forward-looking statements by terminology such as anticipate,“upcoming,”assume,believe,could,estimate,expect,goal